Amgen Inc., AMGN is in the exchange NASDAQ and its industry is Biotechnology in the sector of Healthcare. Based in USA, Amgen Inc., AMGN has a market cap of 121308.3. Since its IPO date on the 9/7/1984, Amgen Inc., AMGN performance year to date is 0.59%. Today Amgen Inc., AMGN has gained 2.88%, with a current price of 161.1.
Ownership of the company is 0.20% for insider ownership while institutional ownership is 81.30%. The management of the company have seen the company have a payout ratio of 35.30%. Return of assets are at 10.00%, with return on investment at 12.50%.
In terms of debt levels and profit levels, Amgen Inc., AMGN is seeing a long-term debt/equity of 1.12. While Total debt/equity is 1.2. With a profit margin of 32.60%, this is combined with a gross margin of 81.00%, and operating margin of 39.90%. Amgen Inc. ability to meet debt levels, with a current ratio of 5, while the quick ratio is 4.7.
For the last year Amgen Inc., AMGN has seen a EPS growth of 35.20%. A performance for the year of 8.97%. The 52-week high is -9.31%, and the 52-week low is 26.15%. The average volume for Amgen Inc., AMGN is 3737303.
With a target price of 183.88, can Amgen Inc., AMGN reach this target? Looking at the value indicators of Amgen Inc., AMGN. Amgen Inc. has a P/E of 17.05 and a forward P/E of 13.23. Perhaps the more useful indicator than P/E, is PEG which has a value of 2.04. Amgen Inc. also has a P/S and a P/B of 5.48 and 4.23 respectively. For P/cash, Amgen Inc. has a value of 3.49, while it is 19.34 for P/free cash flow.
At the current price of 161.1, Amgen Inc. has a dividend yield of 2.48%. We see a return on equity of 25.70%.
Looking more long-term Amgen Inc., is projected to get an EPS growth for the next five years of 8.37%. In the short-term an EPS growth of 8.91% in the next year is forecasted. This is after a EPS growth of 35.20% for this year and for the last five years a 13.60% growth has been seen.